Green Planet Bio Engineering Co. Ltd. (GPLB) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
20807 BISCAYNE BLVD. AVENTURA, FL 33180 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Noncurrent Assets | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 5,000 | 214 | 11,750 | ||||||
| Accounts payable | 214 | ||||||||
| Accrued liabilities | 11,750 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 5,000 | ||||||||
| Other liabilities | 424,590 | ||||||||
| Due to related parties | ✕ | ✕ | 381,920 | 349,387 | 316,458 | 282,645 | 245,751 | ||
| Other undisclosed current liabilities | |||||||||
| Total current liabilities: | 429,590 | 381,920 | 349,387 | 316,458 | 282,859 | 257,501 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 429,590 | 381,920 | 349,387 | 316,458 | 282,859 | 257,501 | |||
| Equity | |||||||||
| Equity, attributable to parent | (429,590) | (381,920) | (349,387) | (316,458) | (282,859) | (257,501) | |||
| Common stock | 20,006 | 20,006 | 20,006 | 20,006 | 20,006 | 20,006 | |||
| Additional paid in capital | 609,614 | 609,614 | 609,614 | 609,614 | 609,614 | 609,614 | |||
| Accumulated deficit | (1,059,210) | (1,011,540) | (979,007) | (946,078) | (912,479) | (887,121) | |||
| Total equity: | (429,590) | (381,920) | (349,387) | (316,458) | (282,859) | (257,501) | |||
Income Statement (P&L) (USD)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (47,370) | (32,533) | (32,929) | (33,599) | (25,358) | (40,239) | ||
| Operating loss: | (47,370) | (32,533) | (32,929) | (33,599) | (25,358) | (40,239) | ||
| Interest and debt expense | (300) | |||||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations: | (47,670) | (32,533) | (32,929) | (33,599) | (25,358) | (40,239) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (32,929) | (33,599) | (25,358) | (40,239) | |
| Other undisclosed net income | 95,340 | 89,358 | 48,689 | |||||
| Net income (loss): | 47,670 | (32,533) | (32,929) | (33,599) | 64,000 | 8,450 | ||
| Other undisclosed net loss attributable to parent | (95,340) | (89,358) | (48,689) | |||||
| Net loss available to common stockholders, diluted: | (47,670) | (32,533) | (32,929) | (33,599) | (25,358) | (40,239) | ||
Comprehensive Income (USD)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 47,670 | (32,533) | (32,929) | (33,599) | 64,000 | 8,450 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 47,670 | (32,533) | (32,929) | (33,599) | 64,000 | 8,450 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.